Market Overview

Oppenheimer Suggests There Might Be 'More Light At The End Of The Tunnel' For Best Buy

Share:

Brian Nagel of Oppenheimer on Friday upgraded shares of Best Buy Co Inc (NYSE: BBY) to Outperform from Perform with an established $43 price target given a view that "the worst is likely over."

Nagel notes that challenges do persist for Best Buy, but a new senior leadership team that has "aggressively" cut costs and "dramatically" improved strategic positioning changes the company's prospects for the better.

Nagel also states that struggling chains such as Sears and Radio Shack closing their operations bodes well for the company. The analyst estimates that both stores could shed as much as $9 billion in share in the consumer electronics and appliance categories.

Nagel believes that Best Buy's management set a low bar for the first half of 2015 which may set up shares for a "that wasn't too bad" type of rally when the company releases its data points.

Finally, Best Buy might chose to re-start share repurchases, according to Nagel who believes that doing so could prove to be a "significant" source of earnings per share upside.

Latest Ratings for BBY

DateFirmActionFromTo
Jul 2019Initiates Coverage OnNeutral
Apr 2019UpgradesHoldBuy
Mar 2019UpgradesPerformOutperform

View More Analyst Ratings for BBY
View the Latest Analyst Ratings

Posted-In: Appliances best buy Brian Nagel consumer electronics Oppenheimer radioshackAnalyst Color Analyst Ratings

 

Related Articles (BBY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ESSMaintains328.0
BKNGMaintains2,080.0
BLKMaintains540.0
AVBMaintains228.0
GOLDDowngrades18.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Here's Why Oppenheimer Upgraded ImmunoGen To Outperform

Barrington Research On GrubHub: 'Strong Results And Savvy Delivery Acquisitions'